NewGenIvf Group annual ebitda
2021
2022
2023
2024
2025
NewGenIvf Group EBITDA Growth & History (NIVF)
NewGenIvf Group's calculated EBITDA was −$10.5M for fiscal 2025.
View full NewGenIvf Group company overviewNewGenIvf Group annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$10.5M | −$9.4M | — |
| 2024 | 2024-12-31 | −$1.1M | −$1.2M | — |
| 2023 | 2023-12-31 | $73,415 | −$425,823 | −85.29% |
| 2022 | 2022-12-31 | $499,238 | $133,771 | +36.60% |
| 2021 | 2021-12-31 | $365,467 | — | — |
NewGenIvf Group quarterly ebitda
No reported data
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|
NewGenIvf Group ebitda trends
Across the available reported history, NewGenIvf Group's ebitda decreased from −$1.1M to −$10.5M, a change of −$9.4M.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review NewGenIvf Group filings at SEC.gov ↗